Sarat Chandarlapaty, M.D., PH.D.
NPI 1013171313ActiveIndividual· Internal Medicine, Medical Oncology· New York, NY
Internal Medicine, Medical Oncology (M.D., PH.D.) in New York, New York, trained at Wake Forest University School of Medicine (class of 2002). Their prescriptions cost Medicare Part D more than their services did: $516,286 for 84 claims, against $10,374 paid for services in 2024. Astrazeneca Pharmaceuticals LP was the largest of 4 companies reporting payments in 2025, $18,055 in all, mostly consulting fees.
Overview
| NPI | 1013171313 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D., PH.D. |
| Sole proprietor | Yes |
| NPI issued | Jul 15, 2008 |
| Last updated in NPPES | Jul 15, 2008 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Medical Oncology Primary | 207RX0202X | 230520 | NY |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Medical Oncology (NJ); Practitioner - Medical Oncology (NY) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 48 |
|---|---|
| Services billed | 113 across 6 procedure codes |
| Paid by Medicare | $10,374 |
Part D prescriptions in 2024
| Prescriptions (claims) | 84 · 116 30-day fills |
|---|---|
| Patients | 30 |
| Total drug cost | $516,286 |
| Generic share | 60% of claims |
Education and affiliations
| Medical school | Wake Forest University School of Medicine |
|---|---|
| Graduation year | 2002 |
| Medicare specialty | Medical Oncology |
| Telehealth | Offers telehealth |
Medical group
- Memorial Solid Tumor GroupNew York, NY · 234 clinicians
Industry payments (Open Payments)
- 2025$18,055 · 6 payments from 4 companies
- 2024$10,904 · 16 payments from 2 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Astrazeneca Pharmaceuticals LP | $7,370 | 1 |
| Merck Sharp & Dohme LLC | $5,760 | 1 |
| Daiichi Sankyo Inc. | $3,125 | 3 |
| Eli Lilly and Company | $1,800 | 1 |
What the 2025 payments were for
- Consulting Fee$18,055 · 6 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Medical Oncology providers in New York
- 1083988513
- 1871784504
- 1295706869
- 1912978487
- 1245945021
- 1316406879
- 1588789341
- 1972877546
- 1972835874
- 1104281245
- 1134190168
- 1598146227
All Internal Medicine, Medical Oncology providers in New York →